验证数据展示
经过测试的应用
Positive IF/ICC detected in | HEK-293 cells |
Positive FC (Intra) detected in | SH-SY5Y cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.80 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-12202 targets MATR3 in IF/ICC, FC (Intra) applications and shows reactivity with human, mouse, rat samples.
经测试应用 | IF/ICC, FC (Intra) Application Description |
经测试反应性 | human, mouse, rat |
免疫原 | MATR3 fusion protein Ag2843 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | matrin 3 |
别名 | Matrin-3, matrin 3, KIAA0723 |
计算分子量 | 847 aa, 95 kDa |
观测分子量 | 125 kDa |
GenBank蛋白编号 | BC015031 |
基因名称 | MATR3 |
Gene ID (NCBI) | 9782 |
RRID | AB_3083920 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P43243 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
MATR3, known as KIAA0723, is a 847 amino acid protein, which may play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. MATR3 was originally identified as a nuclear matrix protein containing both DNA and RNA binding domains (PMID: 2033075) with a wide variety of functions ranging from DNA damage response to transcriptional and post-transcriptional regulation of cellular and viral RNAs(PMID: 21771346). the calculated molecular weight of MATR3 is 94 kDa, but we detect a 125 kDa prtein as result from PMID: 28977530.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 MATR3 antibody CL488-12202 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |